Clinical Trial Update: Antimicrobial Revision in Persistent Febrile Neutropenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an antimicrobial revision for persistent febrile neutropenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Febrile Neutropenia | Phase 4 | Status: WITHDRAWN